Subjects with subjective cognitive decline: 18F-Florbetaben Positrón Emission Tomography Study.
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Florbetaben F18 (Primary)
- Indications Cognition disorders
- Focus Adverse reactions; Diagnostic use
- 02 Nov 2017 Planned initiation date changed from 15 Mar 2017 to 1 Nov 2017.
- 20 Feb 2017 New trial record